San Diego, CA, United States of America

Ekaterina Vinogradova

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Scripps Research Institute, Vividion Therapeutics, Inc.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ekaterina Vinogradova. Retrieved from https://idiyas.com/inventor/ekaterina-vinogradova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ekaterina Vinogradova: Innovator in Cereblon Modulation

Introduction

Ekaterina Vinogradova is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmacology, particularly in the modulation of cereblon neosubstrates. With a total of 3 patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Vinogradova's latest patents focus on "Cereblon modulators and uses thereof." These patents disclose compositions and methods for modulating cereblon neosubstrates. A small molecule modulator of Formula (I*), or a pharmaceutically acceptable salt or solvate thereof, can be utilized to modulate these neosubstrates effectively.

Career Highlights

Throughout her career, Vinogradova has worked with notable organizations such as Vividion Therapeutics, Inc. and The Scripps Research Institute. Her innovative research has garnered attention and respect within the scientific community.

Collaborations

Vinogradova has collaborated with esteemed colleagues, including Benjamin F. Cravatt and Matthew Patricelli. These partnerships have further enhanced her research and contributions to the field.

Conclusion

Ekaterina Vinogradova is a trailblazer in the realm of cereblon modulation, with her patents and collaborations marking significant advancements in pharmacological research. Her work continues to inspire and influence the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…